Patents for A61P 33 - Antiparasitic agents (21,787)
03/1999
03/18/1999CA2302637A1 Vaccine compositions comprising an oil/water emulsion with saponin and sterol
03/17/1999EP0901788A2 Use of inhibitors of the sodium hydrogen exchange in the manufacture of a medicament
03/17/1999EP0901378A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
03/17/1999EP0901375A1 Dhea combination therapy
03/16/1999US5883132 Multistage reaction of amidation, activation, coupling and hydrolysis
03/16/1999US5883080 Antiparastic auermectin derivatives
03/16/1999US5882686 Methods for the prevention and treatment of urogenital disorders
03/16/1999US5882655 Serpulina hyodysenteriae vaccine comprising a hygene mutant
03/16/1999CA2152819C New antiparasitic agents related to the milbemycins and avermectins
03/16/1999CA2086831C Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
03/16/1999CA1340431C Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
03/11/1999WO1999011646A1 Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
03/11/1999WO1999011634A1 Triazine derivatives, their production and use
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999EP0900231A1 Flea protease proteins, nucleic acid molecules, and uses thereof
03/10/1999EP0817624A4 Inhibitors of metazoan parasite proteases
03/10/1999EP0623137B1 Antiparasitic agents
03/10/1999CN1209994A Use of inhibitors of sodium-hyfrogen exchanger for production of pharmaceutical for treatment of disorders which are caused by protozoa
03/09/1999US5880263 Human chemotactic protein
03/09/1999US5879688 Treatment of skin disorders, wrinkling, aging
03/08/1999CA2242476A1 Novel compositions containing cyclosporin
03/04/1999WO1999010333A1 Dicyclanil polymorphs and hydrates and their preparation
03/03/1999EP0898559A2 Cytoprotective compounds
03/03/1999EP0898478A1 Stimulation of host defence mechanisms against tumors
03/03/1999CN1042297C Method for preparing medicinal food
03/02/1999US5877205 Parenteral paclitaxel in a stable non-toxic formulation
03/02/1999US5877178 Aids therapy
03/02/1999US5877159 The gene may encode, e.g., a vaccine antigen, an therapeutic agent, an immunoregulatory agent or a anti-sense rna or a catalytic rna.
03/02/1999US5876966 Compounds and methods for the stimulation and enhancement of protective immune responses and IL-12 production
03/02/1999US5876734 Polypeptides for diagnosing infection with Trypanosoma cruzi
02/1999
02/28/1999CA2246407A1 Use of inhibitors of the sodium-hydrogen exchanger for the production of a pharmaceutical for the treatment of disorders which are caused by protozoa
02/25/1999WO1999008704A1 Method of protecting against chronic infections
02/24/1999EP0897979A2 Human sdr2 cdna clone
02/23/1999US5874530 Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
02/23/1999US5874526 Toxoplasma gondii antigens
02/23/1999US5874434 10,11-methanodibenzosuberane derivatives
02/23/1999US5874403 Amino acid conjugates of cyclohexapeptidyl amines
02/20/1999CA2213385A1 Method of protecting against coccidiosis infections in poultry
02/18/1999WO1999007728A2 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances
02/18/1999WO1999007721A1 Improved process for antiparasitic agent
02/18/1999CA2298932A1 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances
02/17/1999EP0896535A1 Use of substituted aryl imidazoles
02/17/1999EP0896532A1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals
02/16/1999US5871738 Nematode vaccine
02/12/1999CA2239835A1 Human sdr2 cdna clone
02/11/1999WO1999006423A1 83 human secreted proteins
02/11/1999WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
02/11/1999WO1998049311A3 Ricin-like toxin variants for treatment of cancer, viral or parasitic infections
02/11/1999CA2298852A1 83 human secreted proteins
02/11/1999CA2298617A1 Acyclic metalloprotease inhibitors
02/10/1999EP0895999A1 C-4" substituted macrolide antibiotics
02/10/1999EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
02/10/1999EP0597843B1 16 kDa SURFACE PROTEIN OF P. FALCIPARUM
02/10/1999CN1207673A Endoparasiticidal agents
02/09/1999US5869630 Isolated hindiii restriction enzyme dna fragment, 2.3kb from chromosomal dna of bacteria causing swine diarrhea for detection kit with amplification primers and hybridization probes; immunization, vaccines and monitoring of animals
02/09/1999US5869091 Aqueous vehicle, vesicle comprising nonionic surfactant, sterol and charged species suspended in aqueous vehicle and pharmaceutically active agent in both vesicle and aqueous vehicle
02/09/1999CA2226091C Cyclosporin-containing soft capsule preparations
02/04/1999WO1999005156A1 Production of avermectin compounds
02/04/1999WO1999004810A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment
02/04/1999CA2732570A1 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment
02/03/1999EP0703789B1 Vaccine containing a serine protease
02/03/1999CN1207044A Cyclosporin-containing soft capsule preparations
02/02/1999US5866373 Polynucleotide encoding a human chemotactic protein
02/02/1999US5866126 Complexing
02/02/1999US5866123 Gene encoding cationic amino acid transporter protein
01/1999
01/28/1999WO1999003499A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation
01/28/1999WO1998049303A3 Compositions and methods for conferring tick immunity and preventing tick borne diseases
01/27/1999EP0893507A1 Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
01/27/1999EP0892642A1 Use in a composition of an extract of at least one labiate
01/26/1999US5863775 Control of parasites
01/26/1999CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
01/21/1999WO1999002176A1 Methods for treating parasitic infection using thiopeptides
01/21/1999WO1999002150A1 β-ALKOXYACRYLATES AGAINST MALARIA
01/21/1999CA2295924A1 Methods for treating parasitic infection using thiopeptides
01/21/1999CA2294931A1 .beta.-alkoxyacrylates against malaria
01/20/1999EP0774958B1 Vesicle formulation comprising non-ionic surfactant
01/20/1999EP0719259B1 Substituted pyridines and pyrimidines, process for producing them and their use as pesticides and fungicides
01/20/1999EP0573628B1 New a83543 compounds and process for production thereof
01/19/1999US5861436 Inhibitors of the relese of tumor necrosis factor
01/19/1999US5861429 13-substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and other pests
01/19/1999US5861375 Compounds for treatment of malaria, toxoplasmosis and coccidiosis
01/14/1999WO1999001579A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal
01/14/1999WO1999001466A1 Secreted proteins and polynucleotides encoding them
01/14/1999WO1999001452A1 Novel cycloalkyl substituted imidazoles
01/14/1999WO1999001416A2 1-amino-alkylcyclohexane nmda receptor antagonists
01/14/1999WO1999001136A1 Novel substituted imidazole compounds
01/14/1999WO1999001131A1 Novel substituted imidazole compounds
01/14/1999WO1999001130A1 Novel substituted imidazole compounds
01/14/1999CA2295762A1 Novel cycloalkyl substituted imidazoles
01/14/1999CA2295228A1 Novel substituted imidazole compounds
01/14/1999CA2295212A1 Secreted proteins and polynucleotides encoding them
01/14/1999CA2294988A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal
01/14/1999CA2294524A1 Novel substituted imidazole compounds
01/14/1999CA2294522A1 Novel substituted imidazole compounds
01/12/1999US5859271 Inhibitors of phospholipase that prevent phospholipase mediated injury, injury due to oxidation, and inflammation; side effect reduction
01/12/1999US5859196 P30 peptides of Toxoplasma gondii
01/12/1999US5859188 Method for discovering novel anthelmintic compounds
01/12/1999US5859062 Guanylhydrazones and their use to treat inflammatory conditions
01/07/1999WO1999000414A1 Chlamydia trachomatis specific peptides and their use in diagnostic assays
01/07/1999WO1998042740A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection